Liminatus Pharma Completes Iris Parent Acquisition
Ticker: LIMNW · Form: 8-K · Filed: May 6, 2025 · CIK: 1971387
| Field | Detail |
|---|---|
| Company | Liminatus Pharma, Inc. (LIMNW) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, equity-sale, corporate-action
TL;DR
Liminatus Pharma just bought Iris Parent Holding Corp. and sold some stock. Big changes coming.
AI Summary
Liminatus Pharma, Inc. announced on April 30, 2025, the completion of its acquisition of Iris Parent Holding Corp. The company also entered into a material definitive agreement and reported unregistered sales of equity securities. Additionally, Liminatus Pharma disclosed changes in its certifying accountant and material modifications to the rights of security holders.
Why It Matters
This acquisition signifies a major strategic move for Liminatus Pharma, potentially altering its market position and future growth trajectory. The associated equity sales and changes in security holder rights will impact investors.
Risk Assessment
Risk Level: medium — The filing details significant corporate actions including an acquisition, equity sales, and changes to security holder rights, which introduce inherent risks and uncertainties.
Key Players & Entities
- Liminatus Pharma, Inc. (company) — Filer
- Iris Parent Holding Corp. (company) — Acquired Company
- 0001971387 (company) — Central Index Key for Liminatus Pharma
- 20250430 (date) — Report Date
- 20230328 (date) — Date of Name Change from Iris Parent Holding Corp.
FAQ
What was the effective date of the acquisition of Iris Parent Holding Corp. by Liminatus Pharma, Inc.?
The acquisition was completed as of April 30, 2025.
What is the Central Index Key (CIK) for Liminatus Pharma, Inc.?
The CIK for Liminatus Pharma, Inc. is 0001971387.
When did Iris Parent Holding Corp. change its name?
Iris Parent Holding Corp. changed its name on March 28, 2023.
What is the Standard Industrial Classification (SIC) code for Liminatus Pharma, Inc.?
The SIC code for Liminatus Pharma, Inc. is 2836, for Biological Products (No Diagnostic Substances).
What is the business address of Liminatus Pharma, Inc.?
The business address is 6 Centerpointe Dr., #625, La Palma, CA 90623.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Liminatus Pharma, Inc. (LIMNW).